Go Back To Menu
Close
- Mailing Form
-
Medical Report*
-
Go Back To Menu
Skin cancer is a malignant tumor originating from epidermal or melanocytes, mainly including basal cell carcinoma, squamous cell carcinoma, and melanoma. It primarily affects middle-aged and elderly people, with higher risks for those with long-term sun exposure, immunodeficiency, or family history. Early symptoms are often hidden, and if ignored, the disease may metastasize to subcutaneous tissues, lymphatic systems, or even internal organs. Treatment must be comprehensively evaluated based on cancer type, stage, and patient condition. Delayed treatment significantly increases recurrence risk and mortality.
In recent years, immune reconstruction cell therapy has shown promising prospects in treating skin cancer, especially high-risk types such as melanoma. This therapy activates specific immune cells in the patient’s system, such as T cells and NK cells, to achieve targeted killing of cancer cells, enhance immune recognition and clearance, strengthen the body’s anti-tumor response, and reduce recurrence risk.
① Suitable for immunocompromised or metastatic skin cancer patients
② Improves target recognition with longer-lasting effects
③ Fewer side effects, improves quality of life
④ Enhances treatment synergy when combined with surgery and radiotherapy
In practice, tumor patients undergoing surgery, radiotherapy, or chemotherapy often suffer from impaired immunity, increased infection risk, and slow recovery. To help patients better sustain treatment, improve tolerance, and enhance quality of life, phased immune reconstruction programs must be scientifically designed across different treatment cycles.
● Short-term plan: Rapidly boost immunity through immune cell reinfusion to strengthen anti-tumor treatment effects.
● Mid-term plan: Reduce side effects of conventional treatments, promote recovery, and ensure completion of standardized therapy.
● Long-term plan: Comprehensive improvement of immunity through immune cell reconstruction, gut immunity restoration, elemental immunity rebuilding, and immune nutrition support, thereby improving quality of life and prolonging survival.
1. Surgical Excision
Surgery remains the first choice for early-stage skin cancer. For basal cell carcinoma and squamous cell carcinoma, local lesions can be completely cleared by excision. The extent of resection depends on lesion location and depth, with cosmetic repair performed postoperatively if needed. For invasive or organ-adjacent tumors, wider excision combined with other therapies may be required.
2. Radiotherapy
Radiotherapy can serve as postoperative adjuvant therapy or as the primary treatment for elderly or frail patients unsuitable for surgery. High-energy radiation damages cancer cell DNA, preventing replication. Radiotherapy is effective for deep or recurrent lesions, with stable efficacy and relatively mild side effects.
3. Chemotherapy
For advanced or multiple metastatic skin cancers, systemic chemotherapy can slow disease progression. Common drugs such as cisplatin and fluorouracil may be combined with other treatments to control tumor burden. Chemotherapy has significant side effects and is generally used when patients cannot tolerate other treatments or the disease spreads rapidly.
4. Photodynamic Therapy
Photodynamic therapy combines photosensitizers with specific wavelength light sources to trigger local photochemical reactions that kill cancer cells. It is suitable for early non-melanoma types, especially in facial and neck areas, offering fast recovery and good cosmetic outcomes.
Experts at United Life International Medical Center point out that once diagnosed, skin cancer treatment should be precisely tailored according to cancer type and stage. Combining immune reconstruction cell therapy with surgery and various adjuvant measures helps comprehensively control disease, reduce recurrence, and improve survival and quality of life. Actively receiving standardized treatment is key to preventing progression.
